INS and Alzheimer disease: Altogether, insulin and Insulin-like Growth Factor 1 (IGF1) resistance in AD results in a reduced catabolism of cerebral glucose and promotes oxidative stress, mitochondrial dysfunction, pro-inflammatory cytokines activation, and impaired energy metabolism [81,82,83] (Figure 3).